Pharmabiz21h
Chugai Pharma receives Japanese regulatory approval for Lunsumio for intravenous infusion for relapsed/refractory follicular lymphoma
Chugai Pharmaceutical Co., Ltd. announced that it has obtained regulatory approval from the Ministry of Health, Labour and Welfare (MHLW) for “Lunsumio for intravenous infusion 1mg” and “Lunsumio for ...
Pharmabiz1d
Big data transforming healthcare and enabling better patient outcomes, operational efficiencies: Rahul Bajaj
Big data is revolutionizing healthcare and fitness by enabling the collection and analysis of extensive information from medical records, fitness trackers, and other digital tools. This approach ...
Pharmabiz21h
Relief Therapeutics provides update on potential transaction with Renexxion
Relief Therapeutics provides update on potential transaction with Renexxion: Geneva Saturday, December 28, 2024, 18:00 Hrs [IST] Relief Therapeutics Holding SA, a biopharmaceutica ...
Pharmabiz20h
Exicure joins hands with GPCR Therapeutics for growth in biotech
Exicure, Inc., an early-stage biotechnology company, has announced the signing of a Memorandum of Understanding (MoU) with GPCR Therapeutics, Inc., a clinical-stage international biopharmaceutical ...
Pharmabiz22h
Assembly Bio announces interim phase 1b results from trial evaluating next-generation CAM candidate ABI-4334 in chronic hepatitis B
South San Francisco, California Saturday, December 28, 2024, 17:00 Hrs [IST] ...
Pharmabiz18h
Hoth Therapeutics partners with the Department of Veterans Affairs to develop obesity treatment
Hoth Therapeutics, Inc., a biopharmaceutical company focused on developing innovative therapies, announced that it has entered into an exclusive patent license agreement with the US Department of ...
Pharmabiz1d
Takeda gets Japanese MHLW approval for Hyqvia 10% SC injection for patients with agammaglobulinemia or hypogammaglobulinemia
Takeda gets Japanese MHLW approval for Hyqvia 10% SC injection for patients with agammaglobulinemia or hypogammaglobulinemia: Osaka, Japan Saturday, December 28, 2024, 10:00 Hrs [ ...
Pharmabiz1d
US FDA proposes rule to require standardized testing methods for detecting and identifying asbestos in talc-containing cosmetic products
US FDA proposes rule to require standardized testing methods for detecting and identifying asbestos in talc-containing cosmetic products: Maryland Saturday, December 28, 2024, 15: ...
Pharmabiz1d
Dr Sandip Shah takes over as chairman of NABL
Our Bureau, Mumbai Friday, December 27, 2024, 17:15 Hrs [IST] Dr Sandip Shah has taken over as chairman of the National ...
Pharmabiz1d
Parliamentary panel asks NPPA to submit detailed note on 50% price hike on 11 drugs
Parliamentary panel asks NPPA to submit detailed note on 50% price hike on 11 drugs: Gireesh Babu, New Delhi Saturday, December 28, 2024, 08:00 Hrs [IST] A Parliamentary panel has ...
Pharmabiz1d
Viracta Therapeutics announces closure of NAVAL-1 trial and exploration of strategic alternatives
Viracta Therapeutics announces closure of NAVAL-1 trial and exploration of strategic alternatives: San Diego Saturday, December 28, 2024, 11:00 Hrs [IST] Viracta Therapeutics, Inc ...
Pharmabiz1d
India plays a significant role in global MedTech sector especially in emerging markets: Arpit Paliwal
India is playing an increasingly significant role in the global MedTech sector. As the demand for medical technologies rises, especially in emerging markets, India is well-positioned to meet these ...